PortfoliosLab logoPortfoliosLab logo
BIO-key International, Inc. (BKYI)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US09060C4087
CUSIP
09060C408
IPO Date
Feb 14, 1997

Highlights

Market Cap
$4.93M
Enterprise Value
$2.31M
EPS (TTM)
-$0.63
Total Revenue (TTM)
$6.10M
Gross Profit (TTM)
$4.72M
EBITDA (TTM)
-$4.10M
Year Range
$0.49 - $1.97
ROA (TTM)
-42.25%
ROE (TTM)
-59.86%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIO-key International, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in BIO-key International, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

BIO-key International, Inc. (BKYI) has returned -1.67% so far this year and -32.81% over the past 12 months. Over the last ten years, BKYI has returned -46.83% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


BIO-key International, Inc.

1D
-11.35%
1M
-18.98%
YTD
-1.67%
6M
-26.35%
1Y
-32.81%
3Y*
-65.22%
5Y*
-61.80%
10Y*
-46.83%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 21, 2002, BKYI's average daily return is +0.14%, while the average monthly return is -0.29%.

Historically, 41% of months were positive and 59% were negative. The best month was Jan 2009 with a return of +131.6%, while the worst month was Oct 2023 at -63.0%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, BKYI closed higher 38% of trading days. The best single day was Feb 21, 2017 with a return of +404.7%, while the worst single day was Feb 17, 2017 at -80.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202634.58%-9.81%-18.98%-1.67%
2025-21.64%-24.63%-21.88%1.95%4.43%-2.68%-5.82%-2.52%-4.09%8.36%3.63%-33.30%-68.47%
2024-33.33%5.00%0.00%-21.43%17.79%-15.62%-11.58%-8.28%-27.86%37.57%-31.82%90.00%-43.00%
202340.15%-10.98%-4.11%-5.71%18.18%-3.62%-6.76%-27.25%5.86%-62.99%7.61%-22.48%-71.51%
2022-0.90%0.91%8.60%-11.25%-12.68%-4.84%1.69%-5.56%-10.00%1.96%-40.38%-37.09%-73.52%
202110.23%5.15%-14.46%-1.15%16.81%-5.71%-15.79%-1.25%11.39%-9.94%-22.40%-10.16%-37.22%

Benchmark Metrics

BIO-key International, Inc. has an annualized alpha of 38.97%, beta of 0.21, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since February 22, 2002.

  • This stock participated in 167.31% of S&P 500 Index downside but only -6.44% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.21 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
38.97%
Beta
0.21
0.00
Upside Capture
-6.44%
Downside Capture
167.31%

Return for Risk

Risk / Return Rank

BKYI ranks 22 for risk / return — below 22% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


BKYI Risk / Return Rank: 2222
Overall Rank
BKYI Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
BKYI Sortino Ratio Rank: 3030
Sortino Ratio Rank
BKYI Omega Ratio Rank: 3030
Omega Ratio Rank
BKYI Calmar Ratio Rank: 1515
Calmar Ratio Rank
BKYI Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for BIO-key International, Inc. (BKYI) and compare them to a chosen benchmark (S&P 500 Index).


BKYIBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.34

0.90

-1.23

Sortino ratio

Return per unit of downside risk

0.05

1.39

-1.34

Omega ratio

Gain probability vs. loss probability

1.01

1.21

-0.21

Calmar ratio

Return relative to maximum drawdown

-0.72

1.40

-2.12

Martin ratio

Return relative to average drawdown

-1.41

6.61

-8.02

Explore BKYI risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


BIO-key International, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the BIO-key International, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the BIO-key International, Inc. was 99.99%, occurring on Mar 31, 2026. The portfolio has not yet recovered.

The current BIO-key International, Inc. drawdown is 99.99%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Apr 20, 20045519Mar 31, 2026
-74.76%Feb 25, 2002128Aug 26, 2002322Dec 4, 2003450
-30.56%Jan 28, 200430Mar 10, 200411Mar 25, 200441
-22.14%Dec 15, 200311Dec 30, 20039Jan 13, 200420
-12.5%Mar 26, 20043Mar 30, 20046Apr 7, 20049

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of BIO-key International, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how BIO-key International, Inc. is priced in the market compared to other companies in the Security & Protection Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BKYI relative to other companies in the Security & Protection Services industry. Currently, BKYI has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BKYI in comparison with other companies in the Security & Protection Services industry. Currently, BKYI has a P/B value of 0.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items